Types Of Allergic Diseases Research Articles

The Relationship between Interleukin-18 Polymorphisms and Allergic Disease: A Meta-Analysis

Recent studies have suggested that IL-18 −607C/A and −137G/C polymorphisms may be associated with the risk of allergic disease; however, individually published results are inconclusive. Therefore, we performed a meta-analysis to clarify whether IL-18 −607C/A and −137G/C polymorphisms were associated with the risk of allergic disease. A total of 21 studies including 5,331 cases and 9,658 controls were involved in this meta-analysis. In the overall analysis and the subgroup analysis according to ethnicity, we did not find significant association between IL-18 −607C/A or −137G/C polymorphism and the risk of allergic disease (all P > 0.05). However, in a stratified analysis by type of allergic disease, our results indicated that IL-18 −607C/A polymorphism was associated with a significantly decreased risk of allergic asthma in heterozygous comparison and IL-18 −137G/C was associated with a significantly decreased risk of allergic dermatitis in recessive model and homozygous comparison. In the stratified analysis by source of control, IL-18−607C/A showed significantly reduced risk in population-based subgroup, and for IL-18 −137G/C only significantly decreased risk was found in the hospital-based subgroup. Our meta-analysis suggests that IL-18 −607C/A and −137G/C polymorphisms may be protective factors for the risk of allergic asthma and allergic dermatitis, respectively.

Factors associated with cord blood IgE levels

The cord blood IgE level is thought to be a predictor of allergic disorders in childhood. It is not well understood how this marker is influenced by the fetal environment, such as maternal, paternal, placenta, and fetal characteristics. We aimed to investigate the association between cord blood IgE levels and various genetic and environmental factors. This was a cross-sectional study including a total of 181 neonates and their mothers. A questionnaire asking about demographic data, delivery characteristics, maternal past medical history and information on exposure to known environmental allergens was distributed to pregnant women. Blood samples from them and neonatal cord blood samples were taken at the same time for IgE assay. By univariate analysis we found an association between cord blood IgE levels and higher number of previous pregnancies, delivery season, type of delivery, history of allergy during pregnancy, but not the type of allergic disease and history of allergic disease before pregnancy, were associated with elevated cord blood IgElevels. The maternal blood level of IgE was correlated with its level in cord blood. By multivariate analysis, the number of previous pregnancies, the type and season of delivery and a history of allergy during pregnancy and maternal age and blood IgE levels were variables which had a significant association with cord blood IgE levels. Among the evaluated factors, the presence of any kind of allergic disorder in the mother or her family and elevated maternal blood IgE level are associated with the cord blood IgE of the child. Maternal age and smoking, neonatal gender, type of delivery, season of birth and parity are probable predictors.

Allied Health – 3001. Does treatment of gasteroesophageal reflux disease in patients with allergic rhinitis improve allergic symptoms?

Background Allergic rhinitis is the most type of allergic disease among population. Its accurate treatment is very important for cutting off allergic Marche. In the other hand, gasteroesophageal reflux disease (GERD) is one of the most gastrointestinal problems among allergic patients like asthma that it might be the treatment conflict. Despite of asthma, we have a few studies about impacts of GERD treatment on symptoms of allergic rhinitis. In this study we evaluated the correlation of GERD treatment and its effects on improvement of allergic rhinitis.

Fighting allergies beyond symptoms: The European Declaration on Immunotherapy

Fighting allergies beyond symptoms: The European Declaration on Immunotherapy

Immunotoxic Effects of Trichloroethylene and Tetrachloroethylene

Allergic diseases have been increasing worldwide in industrialized countries. The interplay of genetic and environmental factors is involved in the induction and progression of several types of allergic diseases. Recently, there have been many reports that the increase and spread of allergic diseases are related to chronic exposure to several environmental pollutants, such as diesel exhaust particles and formaldehyde. Trichloroethylene (TCE) and tetrachloroethylene (PCE) are categorized into chlorinated organic compounds, and are the most widely used extensively in various industrial processes. As a consequence of their widespread use, TCE and PCE are becoming environmental pollutants. Generally, TCE and PCE exposure causes organ toxicological effects on the liver, kidney, and the central nervous system; however, studies of TCE and PCE exposure-induced immune modulations are limited. In this review, we summarize research into immunotoxic effects, such as allergy hypersensitivity, autoimmune disease, and immunosuppression, of TCE and PCE from experimental animal studies and human epidemiological studies.

Obesity and the prevalence of allergic diseases in schoolchildren

Although the association between obesity and bronchial asthma (BA) has been gaining more attention, few studies have been conducted concerning the relationship between obesity and other allergic diseases. The objective of this study was to determine whether and how childhood obesity is associated with allergic diseases other than BA, such as atopic dermatitis (AD), allergic rhinitis (AR), allergic conjunctivitis (AC), and either AR or AC (AR/AC). A questionnaire was administered to the parents of 50,086 Japanese schoolchildren. Associations between childhood obesity and the various allergic diseases were evaluated by univariate and multivariate logistic models. Significant associations were found between higher body mass index (BMI) and AD (p = 0.03), and lower BMI and AC (p < 0.0001), and AR/AC (p < 0.0001). There was a significantly higher prevalence of BA in girls with obesity (p = 0.009) than in those without obesity. Significantly lower prevalence of AC (p = 0.01) and AR/AC (p = 0.002) among children with obesity, and AR (p = 0.04) and AR/AC (p = 0.0004) among boys with obesity were observed than those without obesity. Those who were obese and had AD were significantly more likely to have severe symptoms (p = 0.01). Overall, childhood obesity has positive associations with BA prevalence and AD severity, whereas it has negative associations with AR and AC prevalence, especially among boys. Changes in the immunologic balance accompanied by obesity might have different effects on each type of allergic disease. Exploring the mechanisms by which childhood obesity affects allergic status should lead to new management options for childhood allergy.

Severity of allergic complaints: The importance of depressed mood

Objective: To evaluate the prevalence of depressive symptoms in patients with different kinds of allergic diseases and the connection of depressive symptoms with the severity, type and seasonality of allergic complaints. Methods: Data was obtained via a cross-sectional multicenter questionnaire survey of 528 patients aged 16–60 years attending six regional in- and outpatient allergy clinics in Hungary in June to July 1998. Consecutive patients completed a structured, self-administered questionnaire containing questions about their current and past allergic complaints. Depressive symptoms were measured by the Shortened Beck Depression Inventory (BDI). Results: 32.2% of patients scored above the normal level (≥10) and 12.5% had clinically significant depressive symptomatology (≥19) by the BDI. These rates were significantly higher than those found in the control group from a national representative population sample (22.4% and 8.3%). Patients with asthma and with perennial symptoms had significantly higher depression scores than patients with other types of allergic diseases. There was a significant association between the severity of depressive symptoms and the severity of allergic complaints independently from age, sex, type and seasonality of the allergic disease, and other current physical illnesses and symptoms tested by the General Linear Model (GLM). Conclusions: Our results draw attention that patients even with mild depressive symptoms have significantly more severe allergic complaints and assess general health state as much worse than those without depressive symptoms in any types of allergic diseases. Diagnosis and treatment of depressive symptoms in allergic patients is of great concern from both a clinical and an economical point of view.

Spectrum of ocular allergy.

To elaborate and review the immunologic spectrum of the five basic types of ocular allergy. Perennial allergic conjunctivitis (PAC) appears to be an extension of seasonal allergic conjunctivitis (SAC) based on the similarity of clinical symptoms and the immune mechanism involved. T helper type 2 (TH2)-type cytokines, increased ratio of TH1/TH2 cytokines and increased statement of adhesion molecules all appear to play an integral role in the inflammatory process of SAC and PAC. Vernal keratoconjunctivitis (VKC), which is a pediatric disease, differs from SAC and PAC by its more severe and chronic nature. Increased numbers of T cells, eosinophils (along with the products of degranulation), chemokines and their receptors may contribute to the more serious symptoms of VKC. Atopic keratoconjunctivitis (AKC) is similar to VKC by the increased concentration of cytokines involved (i.e. interleukin-4 and -5). Despite clinical similarities with VKC, the presence of atopic dermatitis, along with some differences in clinical signs, make AKC a separate entity, which is sometimes referred to as an adult variant of VKC. Giant papillary conjunctivitis has similar cell involvement as VKC and AKC. However, giant papillary conjunctivitis differs from VKC and AKC by the clinical signs present (i.e. the presence of giant papillae) and the necessary concurrent contact lens wear. The important differences and similarities observed in these five types of allergic diseases might help to better treat the patients affected with these disorders.

INHIBITORY EFFECTS OF MAST CELL-MEDIATED ALLERGIC REACTIONS BY CELL CULTURED SIBERIAN GINSENG

The crude drug “Siberian Ginseng (SG)” has long been used in empirical Oriental medicine for the nonspecific enhancement of resistance in humans and animals. In this study, we investigated the effect of cell cultured SG by oral administration in mast cell-mediated allergic reactions. SG dose-dependently inhibited compound 48/80-induced systemic allergy with doses of 10−2 to 1 g/kg 1 h before oral administration. Of special note, SG inhibited systemic allergy with the dose of 1 g/kg by 25%. SG (1 g/kg) also inhibited passive cutaneous allergic reaction by 51%. SG dose-dependently inhibited histamine release from rat peritoneal mast cells. When SG (0.01 mg/ml) was added, the secretion of tumor necrosis factor-α (TNF-α) and interleukin-6 in anti-dinitrophenyl (DNP) IgE antibody-stimulated mast cells was inhibited 39.5% and 23.3%, respectively. In addition, SG inhibited anti-DNP IgE antibody-stimulated TNF-α protein expression in mast cells. Our studies provide evidence that SG may be beneficial in the treatment of various types of allergic diseases.

Selectivity of IgE Responses, Mast Cell Sensitization, and Cytokine Expression in the Immune Response of Brown Norway Rats to Chemical Allergens

Sensitizing chemicals can induce various types of allergic disease, including contact dermatitis and occupational asthma. In the present study we have examined the nature of the immune response induced in Brown Norway (BN) rats by oxazolone (OX), a potent contact allergen, and by trimellitic anhydride (TMA), a chemical known to cause sensitization of the respiratory tract and occupational asthma. BN rats were exposed topically to either OX or TMA at doses selected to achieve similar levels of proliferative activity by draining LNC. Both chemicals stimulated hapten-specific IgG antibody responses, but only TMA induced specific IgE antibody, an increase in total serum IgE, and active sensitization of mast cells. Draining LNC from OX-treated rats expressed elevated IFN-γ mRNA, whereas those from TMA-treated rats expressed elevated IL-5 mRNA compared to controls. Furthermore, Con A-activated draining LNC from rats exposed to TMA, but not OX, released significantly increased concentrations of IL-4. In conclusion, different chemical allergens can induce in the BN rat divergent patterns of IgE response and cytokine expression.

Increased levels of serum IgE in children of mothers with systemic lupus erythematosus.

Various allergic diseases have been described in patients with systemic lupus erythematosus (SLE). In the present study, we evaluated the prevalence of allergic disease and serum IgE levels in 36 children of 26 mothers with SLE. None of the subjects had any rheumatic symptoms. There was at least one type of allergic disease in 28 (78%) of the 36 children of mothers with SLE, as compared with 30% in Japanese control children (P < 0.01). The prevalence of atopic dermatitis and bronchial asthma was higher in children of mothers with SLE (64% and 28%) than in controls (19% and 9%) (P < 0.01, respectively). Fourteen of the 36 subjects (39%) had higher levels of serum IgE than those of normal range for age-matched healthy Japanese children with no atopic family disease in the immediate family history, and these children had atopic disease. Among the 14 children with high serum-IgE levels, seven had neither immediate nor remote family history of atopic disease, while the others had an immediate family history of atopic disease. We think that genetic factors may influence the presence of allergic disease in children of mothers with SLE, and that the increased serum IgE levels in children of SLE mothers with no allergic family history may be a part of subclinical immunologic abnormalities related to SLE.

Genetic risk for asthma, allergic rhinitis, and atopic dermatitis.

In order to explore the genetic risk of a child with a family history of allergies developing asthma, allergic rhinitis, or atopic dermatitis, questionnaires filled in by 6665 families were analysed. The data were collected in a population based cross sectional survey of 9-11 year old schoolchildren living in Munich and southern Bavaria. The relation between asthma, allergic rhinitis, and atopic dermatitis and the number of allergic first degree relatives, and the type of allergic disease was examined. Analyses were done separately for families with single or multiple allergic diseases. In families with one allergic parent the risk of the child developing asthma was increased by asthma in a parent, with an odds ratio (OR) of 2.6 (95% confidence interval 1.7 to 4.0) but not by parental allergic rhinitis with OR 1.0 (0.7 to 1.5) or atopic dermatitis, OR 1.0 (0.6 to 1.6). For allergic rhinitis the highest risk with OR 3.6 (2.9 to 4.6) was observed with allergic rhinitis of one parent, apparently lower for asthma of one parent, OR 2.5 (1.6 to 4.0) or atopic dermatitis, OR 1.7 (1.1 to 2.5). Children with parental atopic dermatitis had a high risk for atopic dermatitis, OR 3.4 (2.6 to 4.4), compared with children with parental asthma, OR 1.5 (1.0 to 2.2), or parental allergic rhinitis, OR 1.4 (1.1 to 1.8). Risk factors in families with combined allergies of two relatives (parents and siblings) were analysed separately for the different combinations. These results support the hypothesis that asthma, allergic rhinitis, and atopic dermatitis are multifactorial diseases brought about by various familial and environmental influences.

Psychological studies of allergic women. The relation between skin reactivity and personality.

Psychological tests were administered to allergic patients differing with respect to diagnosis and severity of reactivity to skin testing with allergens. The results indicate that severity of skin reaction is a significant dimension along which patients differed with respect to personality pattern. Type of allergic disease in small numbers of cases was not found to be a significant dimension in terms of personality configuration.

Prednisone in allergic diseases.

• Prednisone was compared with cortisone as to potency and side-effects in 80 patients with allergic disease. Of 50 patients who had perennial chronic asthma, 41 obtained complete or nearly complete relief with the doses of prednisone that they were able to tolerate. Good or fair results were also obtained with the other types of allergic disease studied. The results were poor only in one case of seasonal allergic rhinitis. Most of the patients obtained improvement from prednisone in doses about one-fifth those required with cortisone. Side-effects of prednisone included gastric complaints, euphoria, increased appetite, and overstimulation. None were serious. Edema was encountered in one patient, rounding of the face in six, and urinary frequency in seven. It appeared that prednisone is far less likely than cortisone to lead to fluid retention.